Miller Kathryn M, Liu Chrissy, Zhou Qin, Iasonos Alexia, Baser Ray, Ramesh Bhavani, Sonoda Yukio, Mueller Jennifer J, Broach Vance, Abu-Rustum Nadeem R, Leitao Mario M
Memorial Sloan Kettering Cancer Center, Department of Surgery, Gynecology Service, New York, NY, USA.
SUNY Downstate Medical Center, Department of Obstetrics and Gynecology, New York, NY, USA.
Int J Gynecol Cancer. 2025 Feb;35(2):100063. doi: 10.1016/j.ijgc.2024.100063. Epub 2024 Dec 20.
To compare the prevalence of patient-reported lower extremity lymphedema and evaluate patient-reported quality of life after sentinel lymph node mapping vs comprehensive lymphadenectomy with or without sentinel lymph node mapping for the surgical management of early-stage cervical cancer.
In July 2022, we mailed a survey that included a validated 13-item lower extremity lymphedema screening questionnaire to patients who underwent lymph node evaluation at the time of primary surgery for the 2018 International Federation of Gynecology and Obstetrics stage IA1 to IIB cervical cancer between January 1, 2006, and January 31, 2019. We excluded patients diagnosed with lower extremity lymphedema prior to surgery and those who answered ≤6 survey items, and we carried out 2 group comparisons: sentinel lymph node mapping vs lymphadenectomy with or without sentinel lymph node mapping, and patients with lower extremity lymphedema vs patients without.
Of 459 potential participants, 90 (20%) responded to the survey, all of which were evaluable (37 sentinel lymph nodes; 53 lymphadenectomies ± sentinel lymph nodes). Self-reported lower extremity lymphedema prevalence was 10.8% (4/37) in the sentinel lymph node mapping group and 43.4% (23/53) in the lymphadenectomy with or without sentinel lymph node mapping group (OR 6.32, 95% CI 2.14 to 23.5, p = .002). Histologic subtype and number of lymph nodes removed were associated with increased prevalence of lower extremity lymphedema. After adjusting for the histology subtype, lymphadenectomy retained independent association with an increased prevalence of lower extremity lymphedema over sentinel lymph node mapping (OR 4.96, 95% CI 1.61 to 18.8, p = .009). Patients with self-reported lower extremity lymphedema had significantly worse quality of life compared to those without self-reported lower extremity lymphedema.
We found sentinel lymph node mapping to be independently associated with a significantly decreased prevalence of patient-reported lower extremity lymphedema and with improved quality of life in patients undergoing surgical management of early-stage cervical cancer.
比较患者报告的下肢淋巴水肿患病率,并评估前哨淋巴结定位术与有或无前哨淋巴结定位术的根治性淋巴结清扫术治疗早期宫颈癌后患者报告的生活质量。
2022年7月,我们向在2006年1月1日至2019年1月31日期间因2018年国际妇产科联盟(FIGO)IA1至IIB期宫颈癌接受初次手术时接受淋巴结评估的患者邮寄了一份调查问卷,其中包括一份经过验证的13项下肢淋巴水肿筛查问卷。我们排除了术前诊断为下肢淋巴水肿的患者以及回答问卷项目数≤6项的患者,并进行了两组比较:前哨淋巴结定位术与有或无前哨淋巴结定位术的淋巴结清扫术,以及有下肢淋巴水肿的患者与无下肢淋巴水肿的患者。
在459名潜在参与者中,90名(20%)回复了调查问卷,所有回复均可供评估(37例前哨淋巴结定位术;53例淋巴结清扫术±前哨淋巴结定位术)。前哨淋巴结定位术组患者报告的下肢淋巴水肿患病率为10.8%(4/37),有或无前哨淋巴结定位术的淋巴结清扫术组为43.4%(23/53)(比值比6.32,95%置信区间2.14至23.5,p = 0.002)。组织学亚型和切除的淋巴结数量与下肢淋巴水肿患病率增加相关。在调整组织学亚型后,淋巴结清扫术与前哨淋巴结定位术相比,仍与下肢淋巴水肿患病率增加独立相关(比值比4.96,95%置信区间1.61至18.8,p = 0.009)。自我报告有下肢淋巴水肿的患者的生活质量明显低于自我报告无下肢淋巴水肿的患者。
我们发现前哨淋巴结定位术与患者报告的下肢淋巴水肿患病率显著降低独立相关,且与接受早期宫颈癌手术治疗的患者生活质量改善相关。